A draft of updated premarket guidance from the U.S. Food and Drug Administration shows that manufacturers should prepare a “cybersecurity bill of materials” before marketing medical devices, GovInfoSecurity reports. The requirement would require manufacturers to produce a list of the components that could be susceptible to vulnerabilities. FDA Commissioner Scott Gottlieb said, "Because of the rapidly evolving nature of cyber threats, we're updating our [premarket] guidance to make sure it reflects the current threat landscape so that manufacturers can be in the best position to proactively address cybersecurity concerns when they are designing and developing their devices." 
Full Story